Office of Entrepreneurial Affairs and Technology Commercialization - Technologies Available

Technologies Available - Biological Sciences

Click on the technology items below to read more.

113036	Non-Invasive PC-MRI Based Hemodynamic Modeling Procedure
112005	Appetite Stimulating Proteins
111098	An Acoustic Jet Device for Sleep Apnea
111064	Hepato-Seal
111017	AKT Selective Cytotoxic Compounds
110068	Metal Stent Coating
110060	A Novel Genetic Marker for Food Allergy
110057	Sinus Dilation Device
110025	Serum Test for Lung and Prostate Cancer
109100	Method of Detection of Heparin Adulteration
109074	Radiation Shielding Device
109051	Allantoin as non-invasive neuroprotective therapy for Parkinson's disease
109034	Membrane Transfer of Pharmaceutical Nanocarriers
109001	A Safer Way to Treat Obesity
108104	Drug/Food Self-Administration v.2.23
108070	A Method of Improving the Efficacy of Currently Available Asthma Drugs
108017	Personalized Medicine - A Test for Individualized Cardiovascular Disease Treatment Protocols Based on Beta-1 Adrenergic Receptor Haplotype
107093	Novel Molecules for Shiga Toxin Detection
107055	RB Functional Status as a Determinant for Breast Cancer Therapy
107054	Novel End-Point Assay for Autophagy
107014	Novel Wound Healing Device
107004	Novel Estrogen Receptor Beta (ER-ß) Isoforms as Targets for Cancer Therapeutics and other ER-ß related diseases.
106109	G-Protein Coupled Receptor Kinase-5 Polymorphism
106082	Structure of human platelet glycoprotein VI: A novel target for anti-thrombotic agents
106078	Polo-like kinase 3 (Plk3) as a Rational Target for Anti-Cancer Therapy
106042	Methods for Diagnosing and Treating Cancers via manipulations of a non-degradative pVHL-Rpb1 ubiquitylation pathway
106026	Molecular Profiling of Thyroid Cancer
105008	Method of Killing Cancer Cells by Neurotransmitter Inhibition
104079	Endovascular Aneurysm Neck Closure Device
104070	Miniature Multisensor Catheter
104062	Glucocorticoid Induced Receptor: A novel Neuropeptide Y “Y2-like” GPCR as a target for obesity
104041	Management of the Newborn Experience
104010	Compounds to Treat Cardiovascular Ischemia and promote Wound Healing
103036	Bisbenzamidines for the Treatment of Pneumonia
103007	Compositions and Methods for Targeted Drug Delivery
102080	The Magnetic Hip Joint For Reduction of Friction
102042	Potential Tumor Suppressor Gene
102037	Method for Determining Dietary Fat Absorption
101033	Method to Increase Milk Production
100037	Enhanced tPA Activity and Therapy
100021	Peptides with Antioxidant and Antimocrobial Properties
099047	Item Number 281 - Detection of Nucleic Acid Target Sequences by Electron Paramagnetic Resonance Spectroscopy
098030	Preparative Chiral Separations
098021	hBub1, Cell Cycle Checkpoint Gene
098013	Compounds to Treat Obesity
097032	Item Number 274 - Self-Destructing, Controlled Release Peroral Drug Delivery System
093008	Synthetic Restriction Enzymes Reagents For Rapid DNA Cleavage & Analysis
090003	Item Number 148 - Analysis Of Whole Blood
085018	Item Number 62 - Aqueous Calcium/Phosphate For Nutritional Solutions